Tanshinone IIA and astragaloside IV attenuate diabetic nephropathy by regulating the SOX6-mediated MAPK/NF-κB pathway to suppress inflammation and oxidative stress

Tissue and Cell · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles